Vote for song
Merge 104.8 | 09 September 2020
A potential COVID-19 vaccine developed by the UK’s Oxford University and AstraZeneca has had its final clinical trials halted after a participant became sick after receiving the injection.
As the BBC reports, pharmaceutical manufacturer AstraZeneca “described it as a “routine” pause in the case of “an unexplained illness.”
The UK-developed vaccine candidate began Phase 3 testing this month with 30,000 participants taking part in the UK, South Africa, the US, and Brazil.
As per the BBC: “The AstraZeneca-Oxford University vaccine is seen as a strong contender among dozens being developed globally.”
While details on the adverse reaction experienced by the trial participant were not released, the individual is expected to recover, the BBC report stated.
A decision from medical regulator the MHRA determining when trials can resume could be forthcoming in a matter of days.
In its report, the BBC stated that: “The Oxford University team believe this process illustrates that they are committed to the safety of their volunteers and the highest standards of conduct in their studies.”
Source: BBC
